Discover inspiring stories of global progress in primary education, health advancements, conservation efforts and more.
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...
A groundbreaking prostate treatment offering life-changing relief for men has reached Far North Queensland, transforming ...
A man from Brighton has spoken out after the NHS agreed to offer a life-extending drug to more men with prostate cancer. Currently only those with prostate cancer that has spread can get abiraterone ...
Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...
NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...
MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...
The NHS has expanded access to a prostate cancer drug across England in a move which could stop 8,000 former cancer patients from being told their illness has returned.
2d
Thousands more to get life-saving prostate cancer drug on NHS after The Sun exposed postcode lottery
THOUSANDS more men will get a life-saving prostate cancer drug on the NHS in a win for The Sun after we revealed the deadly ...
SECuRE trial to continue with no modifications to protocol following Safety Review Committee meeting
HIGHLIGHTSFollowing an interim data review of the Cohort Expansion Phase (Phase II) of the SECuRE trial, the Safety Review ...
The patients received Lutetium (177Lu) rhPSMA-10.1 Injections at both St Bartholomew's Hospital, London, and The James Cook University Hospital, Middlesbrough -- Lutetium (177Lu) rhPSMA-10.1 Injection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback